Unknown

Dataset Information

Phosphoproteomics-based modeling defines the regulatory mechanism underlying aberrant EGFR signaling.


ABSTRACT:

Background

Mutation of the epidermal growth factor receptor (EGFR) results in a discordant cell signaling, leading to the development of various diseases. However, the mechanism underlying the alteration of downstream signaling due to such mutation has not yet been completely understood at the system level. Here, we report a phosphoproteomics-based methodology for characterizing the regulatory mechanism underlying aberrant EGFR signaling using computational network modeling.

Methodology/principal findings

Our phosphoproteomic analysis of the mutation at tyrosine 992 (Y992), one of the multifunctional docking sites of EGFR, revealed network-wide effects of the mutation on EGF signaling in a time-resolved manner. Computational modeling based on the temporal activation profiles

SUBMITTER: Tasaki S 

PROVIDER: S-EPMC2978091 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature